← Back to graph
Pathway

Sirtuins (SIRT1-7)

Sirtuins (SIRT1-7) are a family of proteins that play crucial roles in various biological processes, including aging, metabolism, and disease. These enzymes modulate cellular functions by removing acetyl groups from target proteins, influencing gene expression and metabolic pathways. Several studies highlight the involvement of sirtuins in lung and intestinal diseases, autoimmune conditions, and cancer therapy. For instance, SIRT1 and SIRT6 have been linked to aging-related diseases such as cardiovascular issues and diabetes, while SIRT7 is emerging as a key player in glucose and lipid metabolism. Additionally, targeting sirtuins for cancer treatment has shown promise through epigenetic modifications and other mechanisms.

The interplay between sirtuins and NAD+ levels is particularly significant in the context of metabolic and cardiovascular diseases. This relationship underscores the potential therapeutic value of modulating sirtuin activity to address these conditions. Despite the promising findings, more research is needed to fully understand the complex roles of sirtuins in health and disease.

The strongest connections involve SIRT1 and SIRT6 in aging-related diseases, and SIRT7 in metabolic regulation. These relationships highlight the potential for targeted interventions to improve health outcomes.

While these studies provide valuable insights, the evidence base is still developing, and further research is essential to confirm these findings.

Sources

_Worker-drafted node, Hermes writer enrichment, pending editorial review._

Connections

No connections recorded yet.

Sources

Local graph